KMT2A and acute myeloid leukemia: FLT3_206674_at was the most significantly upregulated probeset (Fold Change in pediatric KMT2A/MLL-R+ AML cells = 7.54; P-value < 1 × 10-8; Fold Change in adult KMT2A/MLL-R+ AML cells = 8.28; P-value < 1 × 10-8) followed by TEC_206301_at (Fold Change in pediatric KMT2A/MLL-R+ AML cells = 2.2; P-value < 1 × 10-8; Fold Change in adult KMT2A/MLL-R+ AML cells = 1.73; P-value < 1 × 10-8) [Supplementary Figures 4 and 5; Supplementary Tables 7 and 8].